Narendra Tripathy

Narendra Tripathy is an accomplished professional in the pharmaceutical industry, holding extensive experience in research and development roles. Currently serving as Vice President of R&D at Neuland Laboratories Limited, Narendra has previously held positions such as Vice President (Director) and AVP (Ass. Director) in API R&D at Emcure Pharmaceuticals Limited, along with Vice President of R&D at Torrent Pharmaceuticals Ltd and Senior Vice President & Head of API R&D at Cadila Pharmaceuticals Limited. Early in the career trajectory, Narendra contributed as a Principal Scientist (GM) in R&D at Emcure Pharmaceuticals. Educationally, Narendra Tripathy has completed post-doctorate studies in Medicinal Chemistry at The University of Kansas and in Synthetic Organic Chemistry at Rutgers University.